Re-engineered antibiotic show potential for treatment of drug-resistant bacteria

Researchers have developed a second-generation of Spectinomycin that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. Also, in 2014, the research team used the approach to create a new class of this antibiotics called spectinamides designed specifically for treatment of drug-resistant tuberculosis (TB). The drugs, which are still in development, use a novel mechanism to accumulate within the cell and inhibit protein synthesis leading to TB cell death.
Source : www.sciencedaily.com      2015/5/26 08:28

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.